-+ 0.00%
-+ 0.00%
-+ 0.00%

Dianthus Therapeutics EVP, CFO & CBO Ryan Savitz reports $11.23 million common share disposal

PUBT·11/12/2026 22:36:22
Listen to the news
Dianthus Therapeutics EVP, CFO & CBO Ryan Savitz reports $11.23 million common share disposal
  • Dianthus Therapeutics EVP, CFO & CBO Ryan Savitz sold 124,042 common shares Nov. 9-12, 2026.
  • The sales matched 124,042 common shares acquired through stock option exercises over the same period.
  • Savitz held no common shares following the transactions; he retained stock options covering 176,884 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001992324-26-000010), on November 12, 2026, and is solely responsible for the information contained therein.